[HTML][HTML] What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the …
F Aldunate, A Fajardo, N Ibañez, F Rammauro… - Frontiers in …, 2023 - frontiersin.org
Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, can have a wide range of clinical …
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, can have a wide range of clinical …
What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of …
A Fabian, F Alvaro, I Natalia, R Florencia, D Hellen… - 2023 - redi.anii.org.uy
Coronavirus disease 2019 (COVID-19), an infectious disease caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, can have a wide range of clinical …
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, can have a wide range of clinical …
[HTML][HTML] ¿ What did we learn from Convalescent plasma treatment in a COVID-19 patient two-time kidney transplanted? A case report from the viral and immune …
F Aldunate, A Fajardo, F Rammauro, H Daghero… - 2022 - europepmc.org
Background: COVID-19, an infectious disease caused by SARS-CoV-2 virus, can provoke a
vast range of clinical manifestations, ranging from asymptomatic to potentially life …
vast range of clinical manifestations, ranging from asymptomatic to potentially life …
[HTML][HTML] WCN24-360 The use of convalescent plasma in a kidney transplant recipient COVID-19 patient: A case report from the perspective of viral load evolution and …
N Ibañez, F Aldunate, A Fajardo… - Kidney International …, 2024 - kireports.org
Methods Nasopharyngeal swab (NS), saliva, tracheal aspirate (TA), and serum samples
were collected from the patient before, during, and after treatment with CP. Viral RNA was …
were collected from the patient before, during, and after treatment with CP. Viral RNA was …
SARS-CoV-2-specific humoral and cellular immunity in renal transplant and haemodialysis patients treated with convalescent plasma
M Lindemann, A Krawczyk, S Dolff, M Konik, H Rohn… - medRxiv, 2020 - medrxiv.org
Background When patients with chronic kidney disease are infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) they can face two specific problems …
respiratory syndrome coronavirus 2 (SARS-CoV-2) they can face two specific problems …
Successful recovery from COVID‐19 in three kidney transplant recipients who received convalescent plasma therapy
S Naeem, R Gohh, G Bayliss… - Transplant Infectious …, 2021 - Wiley Online Library
Abstract Novel coronavirus disease 2019 (COVID‐19) is a highly infectious, rapidly
spreading viral disease that typically presents with greater severity in patients with …
spreading viral disease that typically presents with greater severity in patients with …
Feasibility of convalescent plasma therapy in kidney transplant recipients with severe COVID-19: a single-center prospective cohort study.
A Gupta, VB Kute, HV Patel, DP Engineer… - … : official journal of the …, 2021 - europepmc.org
Objectives There are limited clinical data on feasibility and safety of convalescent plasma
therapy in kidney transplant recipients with severe COVID-19. The present study was …
therapy in kidney transplant recipients with severe COVID-19. The present study was …
[HTML][HTML] A transient effect of convalescent plasma therapy in a patient with severe covonavirus disease 2019: a case report
AR Baek, EJ Choo, JY Kim, TS Ha, SW Park… - Infection & …, 2022 - ncbi.nlm.nih.gov
A 65-year-old male patient with an end-stage renal disease was diagnosed with coronavirus
disease 2019 (COVID-19) by reverse transcription polymerase chain reaction. The patient …
disease 2019 (COVID-19) by reverse transcription polymerase chain reaction. The patient …
[HTML][HTML] Effectiveness of convalescent plasma therapy in a patient with severe COVID-19-associated acute kidney injury
ZZ Brener, A Brenner - Clinical Nephrology. Case Studies, 2021 - ncbi.nlm.nih.gov
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global …
Efficacy of convalescent plasma to treat mild to moderate COVID-19 in kidney transplant patients: a propensity score matching analysis
MP Cristelli, DML Junior, LA Viana… - …, 2022 - journals.lww.com
This observational, prospective, single-center, singlearm cohort study assessed the 30-d
COVID-19–associated lethality in kidney transplant recipients treated with convalescent …
COVID-19–associated lethality in kidney transplant recipients treated with convalescent …
相关搜索
- load evolution convalescent plasma
- immune response convalescent plasma
- immune response load evolution
- renal transplant convalescent plasma
- sars cov convalescent plasma
- covid 19 plasma therapy
- haemodialysis patients convalescent plasma
- sars cov renal transplant
- moderate covid convalescent plasma
- haemodialysis patients renal transplant
- kidney injury plasma therapy
- haemodialysis patients sars cov
- propensity score convalescent plasma
- covid 19 successful recovery
- severe covid plasma therapy